Literature DB >> 33239805

Scientists are harnessing viruses to treat tumours.

Carolyn Brown.   

Abstract

Entities:  

Keywords:  Cancer; Therapeutics; Virology

Year:  2020        PMID： 33239805     DOI： 10.1038/d41586-020-03226-z

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model.

Authors:  Chandini M Thirukkumaran; Zhong Qiao Shi; Gerard J Nuovo; Joanne Luider; Karen A Kopciuk; Yuan Dong; Ahmed A Mostafa; Satbir Thakur; Kathy Gratton; Ailian Yang; Alex C Chin; Matt C Coffey; Victor H Jimenez-Zepeda; Douglas Stewart; Marta Chesi; P Leif Bergsagel; Don Morris
Journal:  Blood Adv       Date:  2019-03-12

2.  Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo.

Authors:  Danielle N Yarde; Rebecca A Nace; Stephen J Russell
Journal:  Exp Hematol       Date:  2013-09-22       Impact factor: 3.084

Review 3.  Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma.

Authors:  Tomas Jelinek; Bruno Paiva; Roman Hajek
Journal:  Front Immunol       Date:  2018-11-16       Impact factor: 7.561
  3 in total
  2 in total

Review 1.  Redrawing therapeutic boundaries: microbiota and cancer.

Authors:  Jonathan Sholl; Gregory D Sepich-Poore; Rob Knight; Thomas Pradeu
Journal:  Trends Cancer       Date:  2021-11-26

Review 2.  Oncolytic Virotherapy and Microenvironment in Multiple Myeloma.

Authors:  Valentina Marchica; Federica Costa; Gaetano Donofrio; Nicola Giuliani
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.